Gemfibrozil in familial and type V hyperlipidaemias. Report of 3 cases.
Gemfibrozil, a lipid lowering agent, was administered to two patients with familial hyperlipidaemia and one patient with insulin dependent diabetes mellitus. It was partially effective in familial hyperlipidaemia. It dramatically reduced triglyceride and cholesterol levels in the patient with Type V hyperlipidaemia and insulin dependent diabetes mellitus. Patients with familial and Type V hyperlipidaemias should be given a trial of gemfibrozil therapy.
Varthakavi
P
P
Department of Medicine, TNM College, Bombay.
Turakhia
D P
DP
Sharma
S
S
Salgaonkar
D S
DS
Nihalani
K D
KD
Joshi
V R
VR
D000328:Adult; D008076:Cholesterol, HDL / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D005260:Female; D015248:Gemfibrozil / Q000627:therapeutic use*; D006801:Humans; D006950:Hyperlipidemia, Familial Combined / Q000188:drug therapy*; D006949:Hyperlipidemias; D014652:Vascular Diseases / Q000150:complications / Q000401:mortality
D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D015248:Gemfibrozil